Literature DB >> 31144240

Probucol promotes high glucose-induced proliferation and inhibits apoptosis by reducing reactive oxygen species generation in Müller cells.

Xuxia Zhou1, ShiBei Ai2, ZhongPing Chen3,4, ChenXiang Li1.   

Abstract

PURPOSE: To explore the protective effect of probucol on human retinal Müller cells cultured in high glucose.
METHODS: Primary Müller cells from human retinas were cultured in complete DMEM. Third-generation Müller cells were identified using glutamine synthetase (GS) antibody and randomly divided into three groups: normoglycemia (NG, 5.5 mmol/L); hyperglycemia (HG, 30 mmol/L); and hyperglycemia (30 mmol/L) with probucol (10 μmol/L; HGPB). After a 24-h intervention, cell proliferation, apoptosis, and cellular reactive oxygen species (ROS) were measured with a CCK-8 kit, flow cytometry, and DCFH-DA probe, respectively. Kelch-like ECH-associated protein 1 (Keap1), NF-E2-related factor 2 (Nrf2), and glutamate cysteine ligase catalytic subunit (GCLC) protein expression were detected by immunofluorescence staining.
RESULTS: For NG, HG, and HGPB, optical density (OD) values for cell proliferation were 0.98 ± 0.23, 0.58 ± 0.11, and 0.73 ± 0.11; apoptotic rates were 2.79 ± 0.52%, 7.70 ± 0.44%, and 4.00 ± 0.95%; and intracellular ROS were 20.89 ± 5.14, 55.17 ± 14.07, and 26.28 ± 4.73, respectively. Compared to NG, OD was markedly decreased (P < 0.01), apoptosis was increased (P < 0.001), and intracellular ROS level was significantly higher than in HG (P < 0.01). Compared to HG, OD was markedly increased (P < 0.01), apoptosis was meaningfully decreased (P < 0.01), and intracellular ROS level was significantly lower than in HGPB (P < 0.01). GS, Keap1, Nrf2, and GCLC had positive expression.
CONCLUSIONS: Probucol could inhibit intracellular ROS generation, promote proliferation, and decrease apoptosis of human retinal Müller cells cultured in high glucose. This might also be associated with Keap1/Nrf2/ARE oxidative stress signaling pathway activation.

Entities:  

Keywords:  Apoptosis; Cell proliferation; Diabetic retinopathy; Probucol; Reactive oxygen species

Mesh:

Substances:

Year:  2019        PMID: 31144240     DOI: 10.1007/s10792-019-01130-8

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  38 in total

1.  GABA(A) receptors in Müller glial cells of the human retina.

Authors:  Bernd Biedermann; Andreas Bringmann; Kristian Franze; Frank Faude; Peter Wiedemann; Andreas Reichenbach
Journal:  Glia       Date:  2004-05       Impact factor: 7.452

2.  Role of NF-E2-related factor 2 in neuroprotective effect of l-carnitine against high glucose-induced oxidative stress in the retinal ganglion cells.

Authors:  Yu Cao; Xin Li; Chen-Jing Wang; Ping Li; Bo Yang; Chun-Bo Wang; Le-Xin Wang
Journal:  Biomed Pharmacother       Date:  2014-12-23       Impact factor: 6.529

3.  Evaluation of vitreous levels of advanced glycation end products and angiogenic factors as biomarkers for severity of diabetic retinopathy.

Authors:  Makiko Katagiri; Jun Shoji; Noriko Inada; Satoshi Kato; Shigehiko Kitano; Yasuko Uchigata
Journal:  Int Ophthalmol       Date:  2017-03-15       Impact factor: 2.031

Review 4.  Natural Nrf2 activators in diabetes.

Authors:  Angélica Saraí Jiménez-Osorio; Susana González-Reyes; José Pedraza-Chaverri
Journal:  Clin Chim Acta       Date:  2015-07-09       Impact factor: 3.786

5.  Probucol inhibited Nox2 expression and attenuated podocyte injury in type 2 diabetic nephropathy of db/db mice.

Authors:  Guangyu Zhou; Yanqiu Wang; Ping He; Detian Li
Journal:  Biol Pharm Bull       Date:  2013       Impact factor: 2.233

6.  The Receptor for Advanced Glycation Endproducts Drives T Cell Survival and Inflammation in Type 1 Diabetes Mellitus.

Authors:  Sean P Durning; Paula Preston-Hurlburt; Paul R Clark; Ding Xu; Kevan C Herold
Journal:  J Immunol       Date:  2016-09-21       Impact factor: 5.422

Review 7.  Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs.

Authors:  Takumi Satoh; Scott R McKercher; Stuart A Lipton
Journal:  Free Radic Biol Med       Date:  2013-07-25       Impact factor: 7.376

8.  Epigenetic modifications of Keap1 regulate its interaction with the protective factor Nrf2 in the development of diabetic retinopathy.

Authors:  Manish Mishra; Qing Zhong; Renu A Kowluru
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-10-09       Impact factor: 4.799

9.  NRF2 plays a protective role in diabetic retinopathy in mice.

Authors:  Zhenhua Xu; Yanhong Wei; Junsong Gong; Hongkwan Cho; James K Park; Ee-Rah Sung; Hu Huang; Lijuan Wu; Charles Eberhart; James T Handa; Yunpeng Du; Timothy S Kern; Rajesh Thimmulappa; Alistair J Barber; Shyam Biswal; Elia J Duh
Journal:  Diabetologia       Date:  2013-11-03       Impact factor: 10.122

Review 10.  Pathophysiology of diabetic retinopathy.

Authors:  Joanna M Tarr; Kirti Kaul; Mohit Chopra; Eva M Kohner; Rakesh Chibber
Journal:  ISRN Ophthalmol       Date:  2013-01-15
View more
  4 in total

Review 1.  Contribution of Müller Cells in the Diabetic Retinopathy Development: Focus on Oxidative Stress and Inflammation.

Authors:  Raul Carpi-Santos; Ricardo A de Melo Reis; Flávia Carvalho Alcantara Gomes; Karin C Calaza
Journal:  Antioxidants (Basel)       Date:  2022-03-23

2.  Hyperglycemia-induced VEGF and ROS production in retinal cells is inhibited by the mTOR inhibitor, rapamycin.

Authors:  Teruyo Kida; Hidehiro Oku; Sho Osuka; Taeko Horie; Tsunehiko Ikeda
Journal:  Sci Rep       Date:  2021-01-21       Impact factor: 4.379

3.  Probucol Prevents Diabetes-Induced Retinal Neuronal Degeneration through Upregulating Nrf2.

Authors:  Heng-Wei Liu; Yong Luo; Yu-Fan Zhou; Zhong-Ping Chen
Journal:  Biomed Res Int       Date:  2020-02-13       Impact factor: 3.411

Review 4.  Snake venom-derived bradykinin-potentiating peptides: A promising therapy for COVID-19?

Authors:  Ahmed S Gouda; Bruno Mégarbane
Journal:  Drug Dev Res       Date:  2020-08-05       Impact factor: 5.004

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.